NCT06514963View on ClinicalTrials.gov

A Trial of HRS-9813 in Healthy Volunteers

PHASE1CompletedINTERVENTIONAL
Enrollment

50

Participants

Timeline

Start Date

July 24, 2024

Primary Completion Date

January 2, 2025

Study Completion Date

January 2, 2025

Conditions
Healthy Volunteers
Interventions
DRUG

HRS-9813

Specified dose on specified days

DRUG

Placebo

Specified dose on specified days

Trial Locations (1)

430030

Tongji Hospital Affiliated to Tongji Medical College of Huazhong University of Science and Technology, Wuhan

All Listed Sponsors
lead

Guangdong Hengrui Pharmaceutical Co., Ltd

INDUSTRY

NCT06514963 - A Trial of HRS-9813 in Healthy Volunteers | Biotech Hunter | Biotech Hunter